Literature DB >> 19871088

STUDIES ON EXPERIMENTAL HYPERTENSION : XIV. THE EFFECT OF INTERMITTENT RENAL ARTERIAL OCCLUSION ON THE BLOOD PRESSURE OF THE DOG.

H Goldblatt1, H Weinstein, J R Kahn.   

Abstract

By means of a silver chain attached to a silver ring around the main renal artery, intermittent renal arterial occlusion, up to 30 minutes daily, was practiced for as long as 5 months in unilaterally nephrectomized dogs. This did not result in the development of persistently elevated blood pressure. Persistent moderate constriction of the renal artery of such animals by a silver clamp, after intermittent temporary occlusion had failed to affect the blood pressure, produced the usual rise of blood pressure, without accompanying significant impairment of renal excretory function. When the renal artery accidentally became persistently constricted to a great degree, or actually occluded, or if occlusion was deliberately produced by continuous pulling of the chain, hypertension and renal insufficiency (the malignant phase) quickly developed. The results do not lend support to the view that brief daily periods of renal ischemia from intrarenal vasospasm, or from any other cause, can produce persistent hypertension of renal origin.

Entities:  

Year:  1941        PMID: 19871088      PMCID: PMC2135133          DOI: 10.1084/jem.73.3.439

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  3 in total

1.  Experimental Hypertension Induced by Renal Ischemia: Harvey Lecture, May 19, 1938.

Authors:  H Goldblatt
Journal:  Bull N Y Acad Med       Date:  1938-09

2.  STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA.

Authors:  H Goldblatt; J Lynch; R F Hanzal; W W Summerville
Journal:  J Exp Med       Date:  1934-02-28       Impact factor: 14.307

3.  STUDIES ON EXPERIMENTAL HYPERTENSION : VII. THE PRODUCTION OF THE MALIGNANT PHASE OF HYPERTENSION.

Authors:  H Goldblatt
Journal:  J Exp Med       Date:  1938-04-30       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.